Page last updated: 2024-10-25

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Vitreoretinopathy, Proliferative

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with Vitreoretinopathy, Proliferative in 1 studies

Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.

Research Excerpts

ExcerptRelevanceReference
"Three new N(1)-alkylcarbonyl-5-fluorouracil derivatives that are prodrugs of 5-fluorouracil (FU), one of them being a co-drug FU-retinoic acid (RA), were studied as potentially effective drugs against postsurgical proliferative vitreoretinopathy (PVR)."7.72Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil. ( Jolimaître, P; Malet-Martino, M; Martino, R, 2003)
"Three new N(1)-alkylcarbonyl-5-fluorouracil derivatives that are prodrugs of 5-fluorouracil (FU), one of them being a co-drug FU-retinoic acid (RA), were studied as potentially effective drugs against postsurgical proliferative vitreoretinopathy (PVR)."3.72Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil. ( Jolimaître, P; Malet-Martino, M; Martino, R, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolimaître, P1
Malet-Martino, M1
Martino, R1

Other Studies

1 other study available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Vitreoretinopathy, Proliferative

ArticleYear
Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil.
    International journal of pharmaceutics, 2003, Jun-18, Volume: 259, Issue:1-2

    Topics: Chemistry, Pharmaceutical; Drug Stability; Fluorouracil; Kinetics; Magnetic Resonance Spectroscopy;

2003